This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Best Growth Stocks to Buy for September 19th
by Zacks Equity Research
VRT, PPC and CRS made it to the Zacks Rank #1 (Strong Buy) growth stocks list on September 19, 2024.
AI & Space Stocks: Two Megatrends to Ride Over the Next Decade
by Andrew Rocco
Technological advances are at the heart of the most significant stock market advances. As the wheels of innovation continue to turn, investors should focus their research on burgeoning megatrends in AI and space.
Why Vertiv Holdings Co. (VRT) Outpaced the Stock Market Today
by Zacks Equity Research
In the most recent trading session, Vertiv Holdings Co. (VRT) closed at $86.99, indicating a +1.43% shift from the previous trading day.
The Zacks Analyst Blog Ubiquiti, Spotify, DocuSign, Vertiv and Universal Health
by Zacks Equity Research
Ubiquiti, Spotify, DocuSign, Vertiv and Universal Health are included in this Analyst Blog.
Buy 5 Large-Cap Growth Stocks for September on Rate Cut Expectations
by Nalak Das
Investment in growth stocks should be fruitful on rate cut hope. Five growth stocks to be purchased for September are DOCU, SPOT, UI, UHS and VRT.
Vertiv Holdings Co. (VRT) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Zacks.com users have recently been watching Vertiv (VRT) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Vertiv Holdings Co. (VRT) Rises Higher Than Market: Key Facts
by Zacks Equity Research
In the latest trading session, Vertiv Holdings Co. (VRT) closed at $75.47, marking a +1.33% move from the previous day.
SOUN Declines 10.5% in a Month: Can AI Push Help the Stock Rebound?
by Aniruddha Ganguly
Despite a strong AI-backed portfolio and an expanding clientele, SOUN's modest near-term prospects make the stock a risky buy.
Zacks.com featured highlights include Vertiv, Charles River Associates, Cabot, Leidos and HCA Healthcare
by Zacks Equity Research
Vertiv, Charles River Associates, Cabot, Leidos and HCA Healthcare are part of the Zacks Screen of the Week article.
Is VRT Stock's Premium Valuation Justified by its Dividend Potential?
by Aniruddha Ganguly
Vertiv's dividend payout is sustainable, given strong prospects driven by solid AI-driven order growth and expanding market share in the thermal management space.
5 Dividend Growth Stocks to Buy in Historically Weak September
by Sweta Killa
Vertiv Holdings, Charles River, Cabot, Leidos Holdings and HCA Healthcare could be solid choices for a historically weak September.
Vertiv Holdings Co. (VRT) Falls More Steeply Than Broader Market: What Investors Need to Know
by Zacks Equity Research
Vertiv Holdings Co. (VRT) closed at $75.06 in the latest trading session, marking a -0.19% move from the prior day.
Investors Heavily Search Vertiv Holdings Co. (VRT): Here is What You Need to Know
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Vertiv (VRT). This makes it worthwhile to examine what the stock has in store.
Vertiv Holdings Co. (VRT) Stock Moves -0.75%: What You Should Know
by Zacks Equity Research
Vertiv Holdings Co. (VRT) closed at $79.92 in the latest trading session, marking a -0.75% move from the prior day.
SOUN Gains 135.9% Year to Date: Is it too Late to Buy the Stock?
by Aniruddha Ganguly
Despite a strong portfolio and an expanding clientele, SOUN's modest near-term prospects make the stock a risky-buy.
Top Stock Picks for Week of August 26, 2024
by Panel Of Zacks Experts
A Tech Stock with Growing Dominance in the Thermal Management Space and a Life Sciences Company with a Strong Pipeline.
Does Vertiv (VRT) Have the Potential to Rally 33.24% as Wall Street Analysts Expect?
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 33.2% in Vertiv (VRT). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Best Growth Stocks to Buy for August 23rd
by Zacks Equity Research
PPC, AGRO, and VRT made it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 23, 2024.
Vertiv Rises 62% Year to Date: Should Investors Buy VRT Stock?
by Aniruddha Ganguly
Vertiv's (VRT) prospects benefit from strong AI-driven order growth and expanding market share in the thermal management space.
4 Stocks With Solid Net Profit Margin to Boost Portfolio Returns
by Anirudha Bhagat
Let us take a look at four top-ranked stocks, WLDN, LEU, VRT and EZPW, with stellar net profit margins that can help create a winning portfolio.
Best Growth Stocks to Buy for August 21st
by Zacks Equity Research
STRL, PPC, and VRT made it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 21, 2024.
Zacks.com featured highlights Leidos, Trane, Cabot, Vertiv and Charles River
by Zacks Equity Research
Leidos, Trane, Cabot, Vertiv and Charles River have been highlighted in this Screen of The Week article.
Vertiv Holdings Co. (VRT) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Vertiv (VRT) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
5 Dividend Growth Stocks to Boost Your Portfolio
by Sweta Killa
Leidos Holdings (LDOS), Trane Technologies (TT), Cabot Corporation (CBT), Vertiv Holdings (VRT) and Charles River (CRAI) could be solid choices for your portfolio.
Is Vertiv (VRT) a Solid Growth Stock? 3 Reasons to Think "Yes"
by Zacks Equity Research
Vertiv (VRT) possesses solid growth attributes, which could help it handily outperform the market.